Neurosense Therapeutics Ltd
Change company Symbol lookup
Select an option...
NRSN Neurosense Therapeutics Ltd
AACIU Armada Acquisition Corp I
IIPR Innovative Industrial Properties Inc
ORI Old Republic International Corp
CECE CECO Environmental Corp
ACAHU Atlantic Coastal Acquisition Corp
CNHI CNH Industrial NV
T AT&T Inc
NOMD Nomad Foods Ltd
MDC MDC Holdings Inc
Go


Based in Israel
Company profile

NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Closing Price
$1.31
Day's Change
-0.05 (-3.68%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.38
Day's Low
1.30
Volume
(Light)
Volume:
39,144

10-day average volume:
119,132
39,144

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.